FDA Rejects Regeneron’s sBLA to Extend EYLEA HD Dosing Interval
Regeneron’s proposal to lengthen EYLEA HD dosing intervals to 24 weeks hits a CRL roadblock. The wait for extended treatment…
New Study Demonstrates AI’s Reliability in Home OCT Analysis for nAMD
Can AI finally match human experts in analyzing home OCT scans for nAMD? A new study says yes. Notal Vision…
latest posts
